[go: up one dir, main page]

WO2006068759A3 - Liposomes containing phytochemical agents and methods for making and using same - Google Patents

Liposomes containing phytochemical agents and methods for making and using same Download PDF

Info

Publication number
WO2006068759A3
WO2006068759A3 PCT/US2005/042493 US2005042493W WO2006068759A3 WO 2006068759 A3 WO2006068759 A3 WO 2006068759A3 US 2005042493 W US2005042493 W US 2005042493W WO 2006068759 A3 WO2006068759 A3 WO 2006068759A3
Authority
WO
WIPO (PCT)
Prior art keywords
liposomes containing
making
methods
same
phytochemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/042493
Other languages
French (fr)
Other versions
WO2006068759A2 (en
Inventor
John Coulthurst
Samuel Guilds Seabrook Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Magellan Companies Inc
Original Assignee
Magellan Companies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magellan Companies Inc filed Critical Magellan Companies Inc
Publication of WO2006068759A2 publication Critical patent/WO2006068759A2/en
Publication of WO2006068759A3 publication Critical patent/WO2006068759A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention encompasses liposomes containing at least one phytochemical useful for treating infectious diseases, cancer, inflammation, tissue injury and the like. In particular, the present invention encompasses liposomal preparations for delivering a composition comprising ellagic acid to a target cell or cells. Such liposomes may also include other therapeutic agents as required by the recipient patient including such compounds as anti-oxidants such as a-tocopherol and optionally a migration control agent. Ellagic acid may be advantageously combined with phosphatidylcholine to provide a liposomal preparation useful for the safe delivery of the phytochemical to a recipient patient.
PCT/US2005/042493 2004-11-22 2005-11-22 Liposomes containing phytochemical agents and methods for making and using same Ceased WO2006068759A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63011604P 2004-11-22 2004-11-22
US60/630,116 2004-11-22

Publications (2)

Publication Number Publication Date
WO2006068759A2 WO2006068759A2 (en) 2006-06-29
WO2006068759A3 true WO2006068759A3 (en) 2006-08-17

Family

ID=36602194

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/042493 Ceased WO2006068759A2 (en) 2004-11-22 2005-11-22 Liposomes containing phytochemical agents and methods for making and using same

Country Status (1)

Country Link
WO (1) WO2006068759A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2437806B (en) * 2006-05-03 2008-10-01 Univ Cardiff Novel therapeutic delivery system
EP1932516A1 (en) * 2006-12-11 2008-06-18 Universiteit Utrecht Holding B.V. Anti-inflammatory compounds containing compositions for treatment of cancer
EP1932517A3 (en) * 2006-12-11 2008-07-16 Universiteit Utrecht Holding B.V. Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof
CN105816498A (en) 2009-04-27 2016-08-03 玫琳凯有限公司 Botanical anti-acne formulations
FR2958851B1 (en) * 2010-04-16 2012-06-29 Xeda International NEW ACTIVE INGREDIENT (S) FORMULATIONS OF VEGETABLE ORIGIN OR THEIR SYNTHETIC OR PLANT EXTRACT (S) CONTAINING THEM, AND LECITHIN
PT2723319T (en) 2011-06-24 2017-05-03 Merz Pharma Gmbh & Co Kgaa Composition comprising an onion extract and liposomes
DE102011114951A1 (en) * 2011-10-06 2013-04-11 Forschungszentrum Jülich GmbH Molecular mixture comprising an amphipathic type of molecule A which has a positive total charge in the hydrophilic region and an amphipathic type of molecule B and a polyphenol C, process for the preparation of the molecule mixture and their use
KR102773605B1 (en) 2011-12-19 2025-02-25 마리 케이 인코포레이티드 Combination of plant extrats to improve skin tone
US20130266615A1 (en) * 2012-04-10 2013-10-10 Bin Wu Non-immunogenic delivery vehicle for beta-, gamma-, and delta-tocopherols and methods of using and making same
US9849077B2 (en) 2014-03-10 2017-12-26 Mary Kay Inc. Skin lightening compositions
WO2015142500A2 (en) * 2014-03-21 2015-09-24 Bodybio Inc. Compositions and methods for treating addiction
US11931451B2 (en) 2016-08-01 2024-03-19 Wisys Technology Foundation, Inc. Skin lightening compounds from fruit seed extracts
AU2021230541A1 (en) * 2020-03-04 2022-10-06 Natreon, Inc. Anti-cancer and anti-proliferative compositions, and methods for their use in treating cancer
CN113397083A (en) * 2021-07-14 2021-09-17 尹东海 Preservative and processing method thereof
CN114732785A (en) * 2022-04-14 2022-07-12 辰欣药业股份有限公司 Allicin injection and preparation method thereof
CN115024339A (en) * 2022-05-16 2022-09-09 江苏大学 A kind of preparation method of botanical nano-pesticide microcapsules

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356633A (en) * 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
US5817334A (en) * 1988-10-05 1998-10-06 Nexstar Pharmaceuticals, Inc. Method of making liposomes with improved stability during drying
US6387418B1 (en) * 1999-04-19 2002-05-14 Stewart And Lynda Resnick Revocable Trust Pomegranate extracts and methods of using thereof
US6544564B1 (en) * 2001-11-27 2003-04-08 Michael Donald Farley Cytotoxic pharmaceutical composition
US6689387B1 (en) * 1999-09-23 2004-02-10 Bioresponse Llc Phytochemicals for treatment of mastalgia and endometriosis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817334A (en) * 1988-10-05 1998-10-06 Nexstar Pharmaceuticals, Inc. Method of making liposomes with improved stability during drying
US5356633A (en) * 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
US6387418B1 (en) * 1999-04-19 2002-05-14 Stewart And Lynda Resnick Revocable Trust Pomegranate extracts and methods of using thereof
US6689387B1 (en) * 1999-09-23 2004-02-10 Bioresponse Llc Phytochemicals for treatment of mastalgia and endometriosis
US6544564B1 (en) * 2001-11-27 2003-04-08 Michael Donald Farley Cytotoxic pharmaceutical composition

Also Published As

Publication number Publication date
WO2006068759A2 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
WO2006068759A3 (en) Liposomes containing phytochemical agents and methods for making and using same
WO2005000245A3 (en) Compositions and methods for increasing telomerase activity
Nounou et al. Liposomal formulation for dermal and transdermal drug delivery: past, present and future
WO2006099169A3 (en) Novel liposome compositions
WO2005120461A3 (en) Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
WO2004105694A3 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
WO2006007384A3 (en) Antibiotics containing borinic acid complexes and methods of use
WO2004056322A3 (en) Antibiotics containing borinic acid complexes and methods of use
WO2004071529A3 (en) Uses of anti-insulin-like growth factor i receptor antibodies
BR0114713A (en) Liposomal formulation of mitoxantrone
CA2412795A1 (en) Improved liposomal camptothecins and uses thereof
WO2011017297A3 (en) Liposomes comprising a calcium phosphate - containing precipitate
AU2003266322A1 (en) Lipid-polymer-conjugates compositions comprising corticosteroids for the treatment of cancer
MX2010002392A (en) Improved brimonidine compositions for treating erythema.
MY143795A (en) Tetrahydropyridoindole derivatives
WO2009093264A3 (en) Pharmaceutical combinations comprising specified age breaker and further drugs, i.a. antihypertensive drugs, antidiabetic drugs etc.
WO2006083779A3 (en) Pharmaceutical composition comprising hydroxylated nebivolol
WO2004045593A3 (en) Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
WO2000040269A3 (en) Pharmaceutical compositions for treatment of diseased tissues
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
WO2007095056A3 (en) Slow intraventricular delivery
WO2000041504A3 (en) Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides
WO2005081742A3 (en) Testosterone oral dosage formulations and associated methods
Vanić Phospholipid vesicles for enhanced drug delivery in dermatology
WO2007064968A3 (en) Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05852080

Country of ref document: EP

Kind code of ref document: A2